Also trades as: MAYNF (OTC) · $vol 0M
MYX.AX ASX
Mayne Pharma Group Limited
1W: +1.4%
1M: -8.4%
3M: -1.0%
YTD: +0.3%
1Y: -45.1%
3Y: -19.0%
5Y: -52.3%
A$2.82 ($1.96)
-0.03 (-1.05%)
Weekly Expected Move ±5.6%
A$3
A$3
A$3
A$3
A$3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$909M
-10.4% ▼
5Y CAGR: -9.3%
Total Liabilities
$519M
-19.5% ▼
5Y CAGR: -6.0%
Shareholders Equity
$391M
+5.6% ▲
5Y CAGR: -12.6%
Cash & Investments
$82M
-18.1% ▼
5Y CAGR: -3.5%
Total Debt
$43M
+4.7% ▲
5Y CAGR: -34.1%
Net Debt
-$39M
-110.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $97M | $102M | $110M | $60M | $82M |
| Short-Term Investments | $0 | $128M | $39M | $41M | $0 |
| Cash & ST Investments | $97M | $220M | $149M | $100M | $82M |
| Net Receivables | $260M | $210M | $193M | $165M | $176M |
| Inventory | $109M | $83M | $75M | $51M | $55M |
| Other Current Assets | $34M | $28M | $24M | $21M | $2M |
| Total Current Assets | $512M | $554M | $461M | $353M | $339M |
| Property, Plant & Equip. | $226M | $51M | $53M | $59M | $55M |
| Goodwill & Intangibles | $450M | $617M | $569M | $542M | $463M |
| Long-Term Investments | -$22M | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $4M | $2M | $61M | $61M | $15M |
| Total Non-Current Assets | $791M | $695M | $683M | $662M | $570M |
| Total Assets | $1.3B | $1.2B | $1.1B | $1.0B | $909M |
| — Liabilities — | |||||
| Accounts Payable | $64M | $32M | $21M | $30M | $25M |
| Short-Term Debt | $405M | $11M | $4M | $35M | $42M |
| Deferred Revenue | $800K | $8M | $0 | $0 | $0 |
| Other Current Liabilities | $143M | $61M | $106M | $52M | $183M |
| Total Current Liabilities | $629M | $311M | $314M | $261M | $260M |
| Long-Term Debt | $0 | $28M | $32M | $0 | $0 |
| Other Non-Current Liab. | $109M | $261M | $333M | $372M | $252M |
| Total Non-Current Liabilities | $120M | $303M | $375M | $383M | $259M |
| Total Liabilities | $765M | $614M | $689M | $644M | $519M |
| — Equity — | |||||
| Common Stock | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B |
| Retained Earnings | -$840M | -$770M | -$944M | -$1.0B | -$1.0B |
| Accumulated OCI | $148M | $170M | $174M | $185M | $178M |
| Total Stockholders Equity | $546M | $634M | $454M | $370M | $391M |
| Total Liabilities & Equity | $1.3B | $1.2B | $1.1B | $1.0B | $909M |
| — Key Metrics — | |||||
| Total Debt | $414M | $48M | $39M | $41M | $43M |
| Net Debt | $317M | -$54M | -$71M | -$19M | -$39M |
| Total Investments | $1M | $128M | $39M | $41M | $0 |